Matches in Wikidata for { <http://www.wikidata.org/entity/Q91034943> ?p ?o ?g. }
Showing items 1 to 50 of
50
with 100 items per page.
- Q91034943 description "2019 թվականին հրատարակված գիտական հոդված" @default.
- Q91034943 description "article scientifique (publié 2019)" @default.
- Q91034943 description "articolo scientifico (pubblicato il 2019)" @default.
- Q91034943 description "artigo científico (publicado na 2019)" @default.
- Q91034943 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q91034943 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91034943 description "bài báo khoa học" @default.
- Q91034943 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91034943 description "scientific article published on 01 January 2019" @default.
- Q91034943 description "wetenschappelijk artikel" @default.
- Q91034943 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q91034943 description "научна статия" @default.
- Q91034943 name "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 name "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 name "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 type Item @default.
- Q91034943 label "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 label "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 label "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 prefLabel "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 prefLabel "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 prefLabel "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 P1433 Q91034943-D2E7DADA-8EF1-4B4C-8F9C-9628C99EB5DB @default.
- Q91034943 P1476 Q91034943-4B1182C0-A1F9-4916-818C-79D44B33FA69 @default.
- Q91034943 P2093 Q91034943-645FB04E-D5E6-47B0-8362-4418849D070D @default.
- Q91034943 P2093 Q91034943-869C853C-04A1-4075-89EA-1D74F44EA70C @default.
- Q91034943 P304 Q91034943-A46AF41E-83C2-4572-971A-1FFAA6F89BB7 @default.
- Q91034943 P31 Q91034943-40A0C7E1-1904-43A7-8B8D-FC980E05D8A9 @default.
- Q91034943 P356 Q91034943-1CE0999E-C681-46FE-882D-FFE13616F5F6 @default.
- Q91034943 P433 Q91034943-30D8CFF4-F64F-47B2-89BC-6E53F82A008C @default.
- Q91034943 P478 Q91034943-BA527BDF-AF02-41DC-860E-FE470C846008 @default.
- Q91034943 P50 Q91034943-B5CAC3E2-1DB2-4AB0-8EEF-4E15921E4170 @default.
- Q91034943 P577 Q91034943-09DB969F-1102-4336-ACEC-655C9E9649E6 @default.
- Q91034943 P698 Q91034943-76EEBDA0-2AAA-45CF-B3AF-B6A044F79FF3 @default.
- Q91034943 P921 Q91034943-6173DCEE-1A6C-4AC6-800A-23D213CB452D @default.
- Q91034943 P356 CIRCULATIONAHA.118.038477 @default.
- Q91034943 P698 30640545 @default.
- Q91034943 P1433 Q578091 @default.
- Q91034943 P1476 "Response by Figtree et al to Letter Regarding Article, "Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study)"" @default.
- Q91034943 P2093 "Gemma A Figtree" @default.
- Q91034943 P2093 "Karin Rådholm" @default.
- Q91034943 P304 "418-419" @default.
- Q91034943 P31 Q13442814 @default.
- Q91034943 P356 "10.1161/CIRCULATIONAHA.118.038477" @default.
- Q91034943 P433 "3" @default.
- Q91034943 P478 "139" @default.
- Q91034943 P50 Q37392165 @default.
- Q91034943 P577 "2019-01-01T00:00:00Z" @default.
- Q91034943 P698 "30640545" @default.
- Q91034943 P921 Q3025883 @default.